From: Comparative efficacy of non-sedating antihistamine updosing in patients with chronic urticaria
Authorref | Drug | Dose (mg) | Efficacy | |
---|---|---|---|---|
Responders/n | % | |||
Finn [17] | Fexofenadine | 120 BD | 46/89 | 51.6 |
Finn [17] | Fexofenadine | 240 BD | 54/83 | 64.9 |
Nelson [18] | Fexofenadine | 120 BD | 33/77 | 42.8 |
Nelson [18] | Fexofenadine | 240 BD | 46/82 | 56.0 |
Giménez-Arnau [19] | Rupatadine | 20 QD | 69/109 | 63.3 |
Dubertret [20] | Rupatadine | 20 QD | 48/67 | 71.6 |
Siebenhaar [21] | Desloratadine | 20 QD | 15/30 | 50.0 |
Staevska [22] | Desloratadine | 10 QD | 7/36 | 19.4 |
Staevska [22] | Desloratadine | 20 QD | 1/29 | 3.4 |
Staevska [22] | Levocetirizine | 10 QD | 8/31 | 25.8 |
Staevska [22] | Levocetirizine | 20 QD | 5/23 | 21.7 |
Krause [23] | Bilastine | 40 QD | 11/20 | 55.0 |
Krause [23] | Bilastine | 80 QD | 12/20 | 60.0 |